Image: NBC NewsU.S. provides experimental Ebola treatment for outbreak in Congo, bringing trials closer
• The U.S. government has provided doses of an experimental antibody drug developed by Mapp Biopharmaceutical to combat the Ebola outbreak in the Congo. • This decision marks a shift in policy, as the U.S. previously stated the treatment would only be available to high-risk American citizens. • The provision of these doses allows for the drug to be used in clinical trials, accelerating the process of determining its efficacy against the virus.
nbcnews.com